• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明显生长激素缺乏的矮小儿童生长激素分泌早期重新评估的结果

Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency.

作者信息

Loche Sandro, Bizzarri Carla, Maghnie Mohamad, Faedda Antonella, Tzialla Chryssoula, Autelli Michele, Casini Maria Rosaria, Cappa Marco

机构信息

Servizio di Endocrinologia Pediatrica, Ospedale Regionale per le Microcitemie, Cagliari, Clinica Pediatrica, Servizio Analisi Chimico Cliniche, IRCCS Policlinico San Matteo, Università di Pavia, Italy.

出版信息

J Pediatr. 2002 Apr;140(4):445-9. doi: 10.1067/mpd.2002.122729.

DOI:10.1067/mpd.2002.122729
PMID:12006959
Abstract

OBJECTIVE

To test the hypothesis that normalization of the growth hormone (GH) response to stimulation in patients with GH deficiency (GHD) and normal magnetic resonance imaging (MRI) of the hypothalamic-pituitary area might occur earlier than at attainment of final height.

STUDY DESIGN

Prepubertal children with short stature (21 boys and 12 girls; age, 5.2-10 years), in whom a diagnosis of GHD was based on a GH response <10 microg/L after 2 pharmacologic tests (clonidine, arginine, or insulin hypoglycemia), and normal MRI of the hypothalamic-pituitary area were studied. After 1 to 6 months, all children underwent reevaluation of GH secretion by means of one of the provocative tests previously used. During that time, none of the children received GH therapy or entered puberty.

RESULTS

A GH response > or =10 microg/L after retesting was found in 28 patients, and a GH response <10 microg/L was found in 5. In 9 patients, the peak GH response at diagnosis was <7 microg/L to both tests used. In 8, the GH response at retesting was > or =10 microg/L and was 9.0 microg/L in the remaining child.

CONCLUSIONS

We suggest that patients with pathologic GH responses to provocative tests but normal MRI should be reevaluated and followed up before a diagnosis of GHD is firmly established.

摘要

目的

检验以下假设,即生长激素缺乏症(GHD)患者且下丘脑 - 垂体区域磁共振成像(MRI)正常,其对刺激的生长激素(GH)反应正常化可能比达到最终身高的时间更早出现。

研究设计

对青春期前身材矮小的儿童(21名男孩和12名女孩;年龄5.2 - 10岁)进行研究,这些儿童中GHD的诊断基于两次药物测试(可乐定、精氨酸或胰岛素低血糖)后GH反应<10μg/L且下丘脑 - 垂体区域MRI正常。1至6个月后,所有儿童通过之前使用的一种激发试验重新评估GH分泌情况。在此期间,没有儿童接受GH治疗或进入青春期。

结果

重新测试后,28名患者的GH反应≥10μg/L,5名患者的GH反应<10μg/L。9名患者在诊断时对所使用的两种测试的GH峰值反应均<7μg/L。8名患者重新测试时的GH反应≥10μg/L,其余1名儿童的GH反应为9.0μg/L。

结论

我们建议,对于对激发试验有病理性GH反应但MRI正常的患者,在明确诊断GHD之前应进行重新评估和随访。

相似文献

1
Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency.明显生长激素缺乏的矮小儿童生长激素分泌早期重新评估的结果
J Pediatr. 2002 Apr;140(4):445-9. doi: 10.1067/mpd.2002.122729.
2
Growth hormone (GH) secretion and pituitary size in children with short stature. Efficacy of GH therapy in GH-deficient children, depending on the pituitary size.身材矮小儿童的生长激素(GH)分泌与垂体大小。生长激素缺乏儿童中生长激素治疗的疗效,取决于垂体大小。
Neuro Endocrinol Lett. 2005 Oct;26(5):447-52.
3
Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.下丘脑 - 垂体轴磁共振成像异常的存在是青春期前非获得性生长激素缺乏儿童对人生长激素治疗最初3年生长反应的重要决定因素。
Clin Endocrinol (Oxf). 2003 May;58(5):647-52.
4
The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults.在诊断年轻成年人生长激素(GH)缺乏症方面,与胰岛素耐量试验相比,测量自发性生长激素分泌的优势。
Clin Endocrinol (Oxf). 2007 Jul;67(1):78-84. doi: 10.1111/j.1365-2265.2007.02842.x. Epub 2007 Apr 27.
5
Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.特发性生长激素缺乏症及下丘脑 - 垂体区域异常患者生长激素治疗结束后的最终身高及生长激素分泌情况
Neuro Endocrinol Lett. 2005 Feb;26(1):19-24.
6
Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.儿童期起病的生长激素(GH)缺乏症(GHD):对青年成人永久性GHD的生长激素状态重新评估及预测标准评价
J Clin Endocrinol Metab. 1999 Apr;84(4):1324-8. doi: 10.1210/jcem.84.4.5614.
7
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.生长激素治疗与青春期对特发性身材矮小和生长激素缺乏症儿童骨骼及身体成分的影响。
Bone. 2005 Nov;37(5):642-50. doi: 10.1016/j.bone.2005.06.012. Epub 2005 Sep 1.
8
Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.既往诊断为生长激素缺乏症患者青春期生长激素重新检测及停止治疗对成人身高的影响
J Clin Endocrinol Metab. 2006 Nov;91(11):4271-6. doi: 10.1210/jc.2006-0383. Epub 2006 Aug 15.
9
Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.生长激素缺乏症儿童的诊断与生长激素(GH)治疗:泰国朱拉隆功纪念医院的经验
J Med Assoc Thai. 2007 Oct;90(10):2047-52.
10
Stability of IGF-I concentration despite divergent results of repeated GH stimulating tests indicates poor reproducibility of test results.尽管重复生长激素刺激试验结果存在差异,但胰岛素样生长因子-I浓度的稳定性表明试验结果的可重复性较差。
Endocr Regul. 2006 Jun;40(2):37-45.

引用本文的文献

1
Accuracy of Glucagon Testing Across Transition in Young Adults With Childhood-Onset GH Deficiency.儿童期起病的生长激素缺乏症青年成人转换期胰高血糖素检测的准确性
J Clin Endocrinol Metab. 2024 Dec 18;110(1):78-90. doi: 10.1210/clinem/dgae408.
2
Transient Isolated, Idiopathic Growth Hormone Deficiency-A Self-Limiting Pediatric Disease with Male Predominance or a Diagnosis Based on Uncertain Criteria? Lesson from 20 Years' Real-World Experience with Retesting at One Center.孤立性、特发性生长激素缺乏症——一种具有男性优势的自限性儿科疾病,还是基于不确定标准的诊断?来自一个中心 20 年重新检测的真实世界经验教训。
Int J Mol Sci. 2024 May 24;25(11):5739. doi: 10.3390/ijms25115739.
3
GH provocative tests stimulate the growth in children with idiopathic short stature.
生长激素激发试验可刺激特发性身材矮小儿童的生长。
Endocrine. 2024 Aug;85(2):849-854. doi: 10.1007/s12020-024-03860-x. Epub 2024 May 15.
4
Identifying patient-related predictors of permanent growth hormone deficiency.识别与患者相关的导致生长激素缺乏症永久性的预测因子。
Front Endocrinol (Lausanne). 2023 Oct 10;14:1270845. doi: 10.3389/fendo.2023.1270845. eCollection 2023.
5
Sex steroid priming in short stature children unresponsive to GH stimulation tests: Why, who, when and how.促性腺激素刺激试验反应不佳的身材矮小儿童的性激素预处理:原因、对象、时机和方法。
Front Endocrinol (Lausanne). 2022 Nov 29;13:1072271. doi: 10.3389/fendo.2022.1072271. eCollection 2022.
6
Sex steroid priming for growth hormone stimulation testing in children and adolescents with short stature: A systematic review.性甾体激素预处理在儿童和青少年身材矮小患者生长激素刺激试验中的应用:系统评价。
Clin Endocrinol (Oxf). 2023 Apr;98(4):527-535. doi: 10.1111/cen.14862. Epub 2022 Dec 22.
7
Efficacy of short-term induction therapy with low-dose testosterone as a diagnostic tool in the workup of delayed growth and puberty in boys.低剂量睾酮短期诱导治疗作为诊断工具在男孩生长发育延迟和青春期延迟检查中的疗效
J Endocrinol Invest. 2022 Dec;45(12):2377-2384. doi: 10.1007/s40618-022-01879-3. Epub 2022 Jul 28.
8
A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial.一种 GH 促分泌素受体激动剂(LUM-201)在儿科 GH 缺乏症试验的受试者中引起的 GH 反应大于标准 GH 促分泌素。
Horm Res Paediatr. 2022;95(1):76-81. doi: 10.1159/000524244. Epub 2022 Mar 30.
9
Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?GH 治疗在达到最终身高附近时对孤立性 GH 缺乏症患者进行生长促进剂量的有效性、经济性和安全性方面。是否需要修改治疗停药标准?
Pediatr Endocrinol Diabetes Metab. 2021;27(4):258-265. doi: 10.5114/pedm.2021.112694.
10
Reduced Effectiveness and Comparable Safety in Biweekly Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.双周和每周给予聚乙二醇化重组人生长激素治疗儿童生长激素缺乏症的疗效降低和安全性相当:一项针对非劣效性阈值目标的四期试验。
Front Endocrinol (Lausanne). 2021 Nov 25;12:779365. doi: 10.3389/fendo.2021.779365. eCollection 2021.